Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
8 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Roivant Sciences Ltd.’s names, not what it holds today.
Patents granted
8
8 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 2 in 2024 and 2 in 2023
Applications published
25
6 of them in 2025
Names they are printed under
4
a subsidiary
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
GENEVANT SCIENCES GMBH a subsidiary
CH, as the owner printed on each patent
15 publishedGENEVANT SCIENCES GMBH a subsidiary
named as the applicant on its applications, in CH
6 publishedIMMUNOVANT SCIENCES GMBH a subsidiary
CH, as the owner printed on each patent
2 publishedImmunovant Sciences GmbH a subsidiary
named as the applicant on its applications, in CH
2 publishedNames not counted (2)
Roivant Sciences Ltd.
Most of its patents print CH; this name counts in BM, US. 5 granted and 3 published under it are not counted.
Roivant Sciences Ltd.
Most of its patents print CH; this name counts in BM, US. 0 granted and 5 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Mar 26, 2024 | 11,938,191 | Block copolymers | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Mar 12, 2024 | 11,926,669 | Anti-FcRn antibody or antigen binding fragment thereof with improved stability | Pharmaceuticals | IMMUNOVANT SCIENCES GMBH |
| Jul 25, 2023 | 11,707,483 | Micellic assemblies | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Jun 27, 2023 | 11,684,584 | Branched peg molecules and related compositions and methods | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Jan 11, 2022 | 11,219,634 | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| May 26, 2020 | 10,660,970 | Nucleic acid constructs and methods of using the same | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| May 12, 2020 | 10,646,582 | Block copolymers | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Sep 24, 2019 | 10,420,790 | Micellic assemblies | Pharmaceuticals | GENEVANT SCIENCES GMBH |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 30, 2025 | 2025/0332112 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | Organic fine chemistry | GENEVANT SCIENCES GMBH |
| Sep 4, 2025 | 2025/0276000 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Jul 10, 2025 | 2025/0223362 | ANTI-FCRN ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF WITH IMPROVED STABILITY | Pharmaceuticals | IMMUNOVANT SCIENCES GMBH |
| Jul 3, 2025 | 2025/0215042 | MANNOSE-TARGETED COMPOSITIONS | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Jun 12, 2025 | 2025/0186599 | BLOCK COPOLYMERS | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Apr 10, 2025 | 2025/0114476 | POLY(ALKYLOXAZOLINE)-LIPID CONJUGATES AND LIPID PARTICLES CONTAINING SAME | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Oct 3, 2024 | 2024/0325552 | BLOCK COPOLYMERS | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Jul 4, 2024 | 2024/0216545 | MRNA DELIVERY CONSTRUCTS AND METHODS OF USING THE SAME | Biotechnology | GENEVANT SCIENCES GMBH |
| May 9, 2024 | 2024/0148663 | PEG LIPIDS AND LIPID NANOPARTICLES | Pharmaceuticals | GENEVANT SCIENCES GMBH |
| Feb 29, 2024 | 2024/0065982 | LIPID NANOPARTICLES FOR DELIVERING THERAPEUTICS TO LUNGS | Pharmaceuticals | GENEVANT SCIENCES GMBH |
What it applied for, 2024 to 2025: Pharmaceuticals 8 · Biotechnology 1 · Organic fine chemistry 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.